We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Allergan plc (“Allergan” or the “Company”) (NYSE: AGN) to AbbVie Inc. (“AbbVie”) (NYSE: ABBV). Under the terms of the deal, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan Share that they hold.
The Allergan merger investigation concerns whether the Board of Allergan breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether AbbVie is underpaying for Allergan shares, thus unlawfully harming Allergan shareholders.
To receive more information, please fill out the form.